GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: Spectinamide 1599 is an analogue of spectinomycin, being developed to treat multi-drug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) [1].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 2-(5-chloro-2-pyridinyl)-N-[(1R,3S,5R,7R,8S,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-yl]acetamide |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Antibiotic 1599 |
| Other databases | |
| CAS Registry No. | 1620153-85-6 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL3315163 |
| GtoPdb PubChem SID | 523352204 |
| PubChem CID | 60173108 |
| Search Google for chemical match using the InChIKey | WFWJNRAXDUDHKA-CYWJWNLKSA-N |
| Search Google for chemicals with the same backbone | WFWJNRAXDUDHKA |
| UniChem Compound Search for chemical match using the InChIKey | WFWJNRAXDUDHKA-CYWJWNLKSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | WFWJNRAXDUDHKA-CYWJWNLKSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖